Building predictive computational models by harnessing the power of high performance computing and high-dimensional biosensor, biomarker and phenotypic data.
We are computational modelers, life science researchers, clinicians, and patient advocacy groups forging a unique cooperative alliance to transform our understanding of brain disorders and accelerate the discovery of new treatments and cures.
Our initial goal is to build the first robust computer simulation of multiple sclerosis to help predict the course of the disorder in individual patients and accelerate the discovery of new diagnostics, treatments and cures.
Orion Alliance Leadership Member Philip De Jager, MD, PhD, Awarded the National MS Society’s 2014 Barancik Prize for Innovation in MS Research
Philip L. De Jager, MD, PhD, Neurologist at Brigham and Women’s Hospital and Associate Professor of Neurology at Harvard Medical School, is the 2014 recipient of the Barancik Prize for Innovation in MS Research, an international award established in 2013 to drive progress in multiple sclerosis (MS) research. Dr….October 23, 2014
2014 KEY OPINION LEADER PROGRAM Thought leaders from industry, academia, government and medical research foundations share their insights on the opportunities and challenges that impact the discovery and development of new therapies. FRESH PERSPECTIVES AND NEW OPPORTUNITIES IN ALZHEIMER’S DISEASE THERAPEUTIC DEVELOPMENT More than 5 million Americans suffer from Alzheimer’s disease today, and without new drugs to prevent or...October 20, 2014
Thursday, October 23, 2014 at 12pm
This webinar will feature Dr. Francis Jeanson, Program Lead, Informatics & Analytics at the Ontario Brain Institute (OBI), who will present the topic “Brain-CODE: A Neuroinformatics Platform for Brain Discovery.”October 14, 2014